Category
Programme
Preclinical
IND Submission
Phase 1/2
Product
Solid Tumours
LEU-001
Head and Neck (SCCHN)
T4
Phase 1/2
LEU-002
Multiple indications
NKG2DL
IND Submission
LEU-003
Multiple indications
ErbB
IND Submission
LEU-005
Multiple indications
NKG2DL (allogeneic)
Preclinical Development
LEU-007
Multiple indications
MUC1
Preclinical Development
LEU-008
Multiple indications
Integrin avb6
Preclinical Development
Haematological
Malignancies
B-cell malignancies
Undisclosed
IND Submission
LEU-004
Multiple indications
NKG2DL (allogeneic)
Preclinical Development
LEU-006
